Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX
· Real-Time Price · USD
12.05
-0.44 (-3.52%)
At close: May 14, 2025, 1:33 PM
Orthofix Medical Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|
| Global Orthopedics Revenue | 124.18M | 115.32M | 107.54M |
| Global Orthopedics Revenue Growth | +7.68% | +7.24% | n/a |
| Global Spine Revenue | 675.31M | 631.32M | 353.17M |
| Global Spine Revenue Growth | +6.97% | +78.76% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 132.98M | 136.48M | 130.14M | 134.12M | 131.69M | 132.28M | 122.08M | 133.43M | 142.6M | 84.79M | 74.78M | 75.73M | 73.47M | 75.36M | 72.41M | 75.67M | 67.23M | 72.21M | 69.47M | 58.53M | 72.18M | 80.42M | 75.89M | 78.8M | 74.17M | 73.88M | 72.6M | 73.8M | 69.75M | 71.35M | 65.56M | 70.88M | 66.81M | 69.77M | 60.3M | 63.99M | 61.53M | 68.45M | 65.48M | 65.45M | 65.45M |
| Selling, General, and Administrative Revenue Growth | -2.56% | +4.87% | -2.97% | +1.84% | -0.45% | +8.36% | -8.50% | -6.43% | +68.17% | +13.39% | -1.26% | +3.09% | -2.51% | +4.08% | -4.31% | +12.56% | -6.90% | +3.95% | +18.69% | -18.91% | -10.25% | +5.97% | -3.69% | +6.25% | +0.39% | +1.76% | -1.62% | +5.80% | -2.25% | +8.84% | -7.50% | +6.09% | -4.23% | +15.71% | -5.77% | +3.99% | -10.11% | +4.55% | +0.04% | 0.00% | n/a |
| Research and Development Revenue | 19.77M | 18.81M | 17.29M | 18.05M | 19.49M | 18.94M | 18.56M | 19.42M | 23.31M | 13.15M | 11.94M | 12.76M | 11.21M | 13.24M | 12.36M | 13.12M | 10.9M | 10.37M | 9.96M | 8.77M | 9.96M | 8.45M | 7.98M | 8.98M | 9.23M | 8.79M | 9.6M | 7.89M | 6.94M | 8.45M | 6.93M | 6.89M | 7.42M | 7.51M | 6.86M | 6.79M | 7.64M | 7.57M | 6.52M | 6.45M | 5.84M |
| Research and Development Revenue Growth | +5.09% | +8.75% | -4.18% | -7.40% | +2.91% | +2.06% | -4.45% | -16.66% | +77.21% | +10.12% | -6.39% | +13.79% | -15.34% | +7.14% | -5.80% | +20.41% | +5.13% | +4.05% | +13.66% | -12.03% | +17.97% | +5.81% | -11.11% | -2.70% | +4.97% | -8.40% | +21.63% | +13.75% | -17.94% | +21.90% | +0.70% | -7.23% | -1.13% | +9.49% | +0.97% | -11.05% | +0.87% | +16.05% | +1.12% | +10.37% | n/a |